Open AccessPrognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases
Author(s) -
Yujiro Nishioka,
Jin Moriyama,
Shuichiro Matoba,
Hiroya Kuroyanagi,
Masaji Hashimoto,
Junichi Shindoh
Publication year - 2017
Publication title -
digestive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.762
H-Index - 69
eISSN - 1421-9983
pISSN - 0253-4886
DOI - 10.1159/000478791
Subject(s) - medicine , oxaliplatin , colorectal cancer , adjuvant , oncology , regimen , chemotherapy , gastroenterology , adjuvant chemotherapy , adverse effect , tegafur , cancer , breast cancer
Although the usefulness of adjuvant chemotherapy has been established in the treatment for stages II/III colorectal cancer, its prognostic advantage for colorectal liver metastases (CLM) remains controversial.